Table 2.
Clinicoradiographic indications | CT Protocol |
---|---|
Screening for pulmonary metastasis | NCCT |
As part of Lung Cancer Screening Program | LDCT |
Unexplained dyspnoea on exertion, suspected or known case of ILD (e.g. In connective tissue diseases, rheumatological disorders), follow -up of ILD | NCCT |
Suspected or known bronchiectasis, small airway disease | NCCT/LDCT |
PUO | CECT (chest and abdomen) |
Non-resolving pneumonia | CECT |
Mediastinal widening | CECT |
Malignant pleural effusion, empyema, chest wall disease | CECT |
Staging and follow-up of lung cancer | CECT, Biphasic protocols* |
Staging and follow -up of lymphoma | CECT (neck, chest and abdomen) |
Unexplained vocal cord palsy | CECT |
Evaluation of solitary pulmonary nodules | CECT, Dynamic multiphase CT |
Blunt or penetrating chest trauma | CECT, CTA |
Recurrent/Significant haemoptysis | CTA, Split-bolus CTA |
Atypical chest pain (additional diagnosis other than acute coronary syndrome is considered e.g., Pulmonary embolism or aortic dissection) | CTA |
Intermediate to high clinical probability of pulmonary thromboembolism or positive D-dimer level including pregnant patients (ACR Appropriateness Criteria, revised 2016) |
CTPA |
NCCT- refers to routine non contrast CT as detailed in the text; ILD- interstitial lung disease ;CECT - Contrast enhanced CT; CTPA- CT pulmonary angiography; CTA - CT angiography; *. Is used when these are to be used in special situations detailed in text